Clinical trial · Interventional
Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma
Phase II Study Evaluating Strategies of Lung Surveillance of Patients Operated of High Grade Soft Tissue Sarcoma: Chest Radiograph Versus Chest CT
NCT01612481CI-TRIAL-00105589CASSANDREterminatedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): lack of enrollment
Summary
Brief summary (as posted)
Cancer surveillance has a significant cost and generate anxiety for the patient. It is important to avoid exams that will not modify health support or whose results wont allow to decide.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Metastasis | Sarcoma | PROBABILISTIC | 0.70 |
| Soft Tissue Sarcoma | Soft Tissue Sarcoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chest CT | Procedure | — | UNRESOLVED |
| chest radiography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- chest radiography
- description
- clinical exam + chest radiography every 3 months during 2 years and every 6 months during 1 year
- interventionNames
- Procedure: chest radiography
- type
- ACTIVE_COMPARATOR
- label
- chest CT
- description
- clinical exam + Chest CT every 3 months during 2 years and every 6 months during 1 year
- interventionNames
- Procedure: chest CT
Primary outcomes (1)
- measure
- proportion of patients having an isolated and operable pulmonary relapse
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * soft tissue sarcoma, histologically proven * tumor size \> 5 cm (SBR grade 2) or whatever size (SBR grade 3) * complete excision (R0 or R1) * no metastasis (checked by spiral chest CT) * social security covered * informed signed consent Exclusion Criteria: * bone, visceral, uterine, retroperitoneal sarcoma * GIST * other malignant tumor * patients over 70, or for whom thoracic surgery is excluded * pneumoconiosis or known system disease * breast feeding or pregnant woman * patient unable to undergo trail medical follow up for geographic, social or psychological reasons
References
Publications (0)
Data not yet available
No reference posted for this study.